nternational workshop – Bari, 12th-13th December 2016

The main topic of this conference is the translation of nanotherapeutics into clinics and into Pharmaceutical products. One of the first nanotherapeutics was DOXIL, which was approved by FDA for use in clinics in the 1990th.

The conference will offer the possibility to get the firsthand insights from the researcher who developed DOXIL over a new type of nanotoxicity that was discovered with approval of DOXIL to the Pharmaceutical Industry opinion on nanodrugs.

The nanodrug translation into products will be complemented by innovative nanomaterials for different medical applications awaiting for translation. Finally, the conference will introduce a new player in the field of cancer, the extracellular vesicles including exosomes and their application in cancer diagnosis and treatment